192 related articles for article (PubMed ID: 30580909)
1. Initial diagnostic workup of parkinsonism: Dopamine transporter positron emission tomography versus susceptibility map-weighted imaging at 3T.
Sung YH; Lee J; Nam Y; Shin HG; Noh Y; Hwang KH; Lee H; Kim EY
Parkinsonism Relat Disord; 2019 May; 62():171-178. PubMed ID: 30580909
[TBL] [Abstract][Full Text] [Related]
2. A prospective multi-centre study of susceptibility map-weighted MRI for the diagnosis of neurodegenerative parkinsonism.
Sung YH; Kim JS; Yoo SW; Shin NY; Nam Y; Ahn TB; Yoo D; Lee KM; Kim HG; Koh SB; Kim J; Kim I; Kwon DY; Lee Y; Kim C; Chung SJ; Jo S; Lee SH; Kim SJ; Kim M; Lyoo CH; Baek MS; Kang SY; Chang SK; Jo SW; Lee SA; Ma HI; Kim YE; Kim ES; Kim YJ; Kim HS; Woo MH; Choi HJ; Kim EY
Eur Radiol; 2022 May; 32(5):3597-3608. PubMed ID: 35064313
[TBL] [Abstract][Full Text] [Related]
3. Determining the Degree of Dopaminergic Denervation Based on the Loss of Nigral Hyperintensity on SMWI in Parkinsonism.
Bae YJ; Song YS; Kim JM; Choi BS; Nam Y; Choi JH; Lee WW; Kim JH
AJNR Am J Neuroradiol; 2021 Apr; 42(4):681-687. PubMed ID: 33509919
[TBL] [Abstract][Full Text] [Related]
4. Comparison of susceptibility-weighted imaging and susceptibility map-weighted imaging for the diagnosis of Parkinsonism with nigral hyperintensity.
Bae YJ; Song YS; Choi BS; Kim JM; Nam Y; Kim JH
Eur J Radiol; 2021 Jan; 134():109398. PubMed ID: 33264728
[TBL] [Abstract][Full Text] [Related]
5. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
[TBL] [Abstract][Full Text] [Related]
6. Deep learning regressor model based on nigrosome MRI in Parkinson syndrome effectively predicts striatal dopamine transporter-SPECT uptake.
Bae YJ; Choi BS; Kim JM; Ai WA; Yun I; Song YS; Nam Y; Cho SJ; Kim JH
Neuroradiology; 2023 Jul; 65(7):1101-1109. PubMed ID: 37209181
[TBL] [Abstract][Full Text] [Related]
7. Comparative Performance of Susceptibility Map-Weighted MRI According to the Acquisition Planes in the Diagnosis of Neurodegenerative Parkinsonism.
Lee S; Suh CH; Jo S; Chung SJ; Heo H; Shim WH; Lee J; Kim HS; Kim SJ; Kim EY
Korean J Radiol; 2024 Mar; 25(3):267-276. PubMed ID: 38413111
[TBL] [Abstract][Full Text] [Related]
8. The phase value of putamen measured by susceptibility weighted images in Parkinson's disease and in other forms of Parkinsonism: a correlation study with F18 FP-CIT PET.
Kwon GH; Jang J; Choi HS; Hwang EJ; Jung SL; Ahn KJ; Kim BS; Yoo IeR; Kim SH; Haacke EM
Acta Radiol; 2016 Jul; 57(7):852-60. PubMed ID: 26377263
[TBL] [Abstract][Full Text] [Related]
9. Segmentation-based MR attenuation correction including bones also affects quantitation in brain studies: an initial result of 18F-FP-CIT PET/MR for patients with parkinsonism.
Choi H; Cheon GJ; Kim HJ; Choi SH; Lee JS; Kim YI; Kang KW; Chung JK; Kim EE; Lee DS
J Nucl Med; 2014 Oct; 55(10):1617-22. PubMed ID: 25134529
[TBL] [Abstract][Full Text] [Related]
10.
Yang HJ; Park SH; Seo M; Weon YC; Kim Y
Neurotoxicology; 2018 Jan; 64():78-84. PubMed ID: 28259768
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of drug-induced parkinsonism based on [18F] FP-CIT positron emission tomography.
Shin HW; Kim JS; Oh M; You S; Kim YJ; Kim J; Kim MJ; Chung SJ
Neurol Sci; 2015 Feb; 36(2):269-74. PubMed ID: 25231645
[TBL] [Abstract][Full Text] [Related]
12. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
[TBL] [Abstract][Full Text] [Related]
13. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism.
Booij J; Speelman JD; Horstink MW; Wolters EC
Eur J Nucl Med; 2001 Mar; 28(3):266-72. PubMed ID: 11315592
[TBL] [Abstract][Full Text] [Related]
14. Additional Role of Midbrain F-18 FP-CIT Uptake on PET in Evaluation of Essential Tremor and Parkinsonism.
Lee H; Sung YH; Hwang KH
Curr Med Imaging; 2023; 19(9):1041-1051. PubMed ID: 36734891
[TBL] [Abstract][Full Text] [Related]
15. Comparison of perfusion 18F-FP-CIT PET and 99mTc-ECD SPECT in parkinsonian disorders.
Chun K; Kong E; Cho I
Medicine (Baltimore); 2021 Aug; 100(34):e27019. PubMed ID: 34449475
[TBL] [Abstract][Full Text] [Related]
16. The clinical application of nigrosome 1 detection on high-resolution susceptibility-weighted imaging in the evaluation of suspected Parkinsonism: The real-world performance and pitfalls.
Lee J; Lee AL; Park JH; Moon JE; Park JM; Kim SJ; Chang KH
PLoS One; 2020; 15(4):e0231010. PubMed ID: 32240236
[TBL] [Abstract][Full Text] [Related]
17. Unsupervised clustering of dopamine transporter PET imaging discovers heterogeneity of parkinsonism.
Suh M; Im JH; Choi H; Kim HJ; Cheon GJ; Jeon B
Hum Brain Mapp; 2020 Nov; 41(16):4744-4752. PubMed ID: 32757250
[TBL] [Abstract][Full Text] [Related]
18. Nigrosome 1 visibility and its association with nigrostriatal dopaminergic loss in Parkinson's disease.
Kim HK; Kim T; Baek MS; Kim EY; Sung YH; Lee JH; Ryu YH; Ahn SJ; Yoo HS; Lyoo CH
Eur J Neurol; 2023 Jun; 30(6):1639-1647. PubMed ID: 36915220
[TBL] [Abstract][Full Text] [Related]
19. Salivary Gland Uptake on
Kang SY; Yun JY; Kang YK; Moon BS; Yoon HJ; Yoo MY; Kim BS
Korean J Radiol; 2023 Jul; 24(7):690-697. PubMed ID: 37404111
[TBL] [Abstract][Full Text] [Related]
20. Correlation between neuromelanin-sensitive MR imaging and (123)I-FP-CIT SPECT in patients with parkinsonism.
Kuya K; Shinohara Y; Miyoshi F; Fujii S; Tanabe Y; Ogawa T
Neuroradiology; 2016 Apr; 58(4):351-6. PubMed ID: 26779912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
